[go: up one dir, main page]

KR910000159A - 코르티코 스테로이드 함유 연고제 - Google Patents

코르티코 스테로이드 함유 연고제 Download PDF

Info

Publication number
KR910000159A
KR910000159A KR1019900005058A KR900005058A KR910000159A KR 910000159 A KR910000159 A KR 910000159A KR 1019900005058 A KR1019900005058 A KR 1019900005058A KR 900005058 A KR900005058 A KR 900005058A KR 910000159 A KR910000159 A KR 910000159A
Authority
KR
South Korea
Prior art keywords
ointments containing
containing corticosteroids
weight
ointment
corticosteroids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1019900005058A
Other languages
English (en)
Other versions
KR950010157B1 (ko
Inventor
다까시 나루이
데쯔오 가네꼬
가쯔미 이마모리
아끼라 이와사
Original Assignee
다이도 나오가따
에스에스 세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다이도 나오가따, 에스에스 세이야꾸 가부시끼가이샤 filed Critical 다이도 나오가따
Publication of KR910000159A publication Critical patent/KR910000159A/ko
Application granted granted Critical
Publication of KR950010157B1 publication Critical patent/KR950010157B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

내용 없음

Description

중추신경계 질환치료 및 뇌 혈류 촉진용 제제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 실시예 1~3 및 비교예 1~5의 연고제의 혈광수축 시험의 결과를 나타내는 도면이다.

Claims (2)

  1. 다음 성분 (a)(b) (a) 데프로돈 프로피로네이트 0.05~1중량% (b) 백색와세린과 액상 탄화수소로 된 기제 89~99.99중량%를 함유하는 연고제.
  2. 제1항에 있어서, (c) 다가알코올류 1~10중량%를 함유하는 연고제.
    ※참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900005058A 1989-06-21 1990-04-12 코르티코스테로이드 함유 유성 연고제 Expired - Fee Related KR950010157B1 (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP159064/89 1989-06-21
JP89-159064 1989-06-21
JP1159064A JP2655190B2 (ja) 1989-06-21 1989-06-21 コルチコステロイド含有軟膏剤
JP1171125A JP2646025B2 (ja) 1989-06-21 1989-07-04 コルチコステロイド含有ローション剤
JP1171126A JP2660198B2 (ja) 1989-06-21 1989-07-04 コルチコステロイド含有外用クリーム製剤
SG1996005697A SG47072A1 (en) 1989-06-21 1990-09-03 Water-containing external preparations

Publications (2)

Publication Number Publication Date
KR910000159A true KR910000159A (ko) 1991-01-29
KR950010157B1 KR950010157B1 (ko) 1995-09-11

Family

ID=40139923

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1019900004978A Expired - Fee Related KR950015063B1 (ko) 1989-06-21 1990-04-11 함수성 외용제
KR1019900005058A Expired - Fee Related KR950010157B1 (ko) 1989-06-21 1990-04-12 코르티코스테로이드 함유 유성 연고제

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1019900004978A Expired - Fee Related KR950015063B1 (ko) 1989-06-21 1990-04-11 함수성 외용제

Country Status (7)

Country Link
US (2) US5094851A (ko)
EP (2) EP0473810B1 (ko)
JP (3) JP2655190B2 (ko)
KR (2) KR950015063B1 (ko)
DE (2) DE69019151T2 (ko)
ES (2) ES2090066T3 (ko)
SG (1) SG47072A1 (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101103506B1 (ko) * 2007-07-19 2012-01-09 수자원기술 주식회사 관내부 라이닝을 위한 장치

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5632975A (en) * 1995-03-09 1997-05-27 Earles; R. Martin Composition and method for treatment of dermatitis on the scalp
KR19990008108A (ko) * 1995-04-27 1999-01-25 이시하라소이치 에메다스틴을 함유하는 외용제
US6228351B1 (en) 1999-05-27 2001-05-08 Daniel E. Viders Medicated lip balm
US6203796B1 (en) 1999-07-08 2001-03-20 Andreas D. Papaprodromou Oregano-based therapeutic composition
JP4653282B2 (ja) * 2000-05-23 2011-03-16 昭和薬品化工株式会社 ミノサイクリン含有組成物
WO2002026237A1 (fr) * 2000-09-26 2002-04-04 Nisshin Pharma Inc. Preparation liquide de prednisolone phosphate de sodium
DE10062747C2 (de) * 2000-12-15 2003-04-10 Dornier Medtech Holding Int Gmbh Koppelmittel zum schmerzreduzierten Einleiten von Schallwellen in den menschlichen Körper
JP3717158B2 (ja) 2001-11-09 2005-11-16 本田技研工業株式会社 油圧バルブ
WO2004100918A1 (ja) * 2003-05-13 2004-11-25 The Nisshin Oillio, Group, Ltd. 水中油型乳化化粧料
JP4362120B2 (ja) * 2003-05-13 2009-11-11 日清オイリオグループ株式会社 水中油型乳化化粧料
JP2006141858A (ja) * 2004-11-24 2006-06-08 Toppan Printing Co Ltd 化粧料容器及びその製造方法
MX2012007229A (es) * 2009-12-22 2012-07-30 Leo Pharma As Composicion cutanea que comprende analogo de vitamina d y mezcla de solvente y tensioactivos.
JP5965187B2 (ja) * 2012-03-30 2016-08-03 小林製薬株式会社 油性軟膏剤

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1159490A (en) * 1966-02-09 1969-07-23 Boots Pure Drug Co Ltd Improvements in Acylated Steroids
US3639434A (en) * 1967-02-02 1972-02-01 Boots Pure Drug Co Ltd 17-acyloxysteroids and their manufacture
GB1379730A (en) * 1970-12-17 1975-01-08 Glaxo Lab Ltd Pharmaceutical compositions
US3881000A (en) * 1971-09-08 1975-04-29 Mundipharma Ag Bis-(phosphorylated anthralin) compounds in the treatment of psoriasis and arthritis
US3906108A (en) * 1973-10-12 1975-09-16 Johnson & Johnson Stabilized tretinoin cream emulsion
US4294852A (en) * 1973-11-01 1981-10-13 Johnson & Johnson Skin treating compositions
US4124707A (en) * 1976-12-22 1978-11-07 Schering Corporation 7α-Halogeno-3,20-dioxo-1,4-pregnadienes, methods for their manufacture, their use as anti-inflammatory agents, and pharmaceutical formulations useful therefor
US4214000A (en) * 1978-10-30 1980-07-22 Johnson & Johnson Zinc salt of all-trans-retinoic acid for the treatment of acne
JPS56135416A (en) * 1980-03-27 1981-10-22 Mitsubishi Chem Ind Ltd Pharmaceutical preparation for skin
SE8004580L (sv) * 1980-06-19 1981-12-20 Draco Ab Farmaceutisk beredning
JPS59139315A (ja) * 1983-01-31 1984-08-10 Taisho Pharmaceut Co Ltd クリ−ム剤
JPS6028927A (ja) * 1983-07-28 1985-02-14 Shiseido Co Ltd 皮膚外用剤
JPS6028926A (ja) * 1983-07-28 1985-02-14 Shiseido Co Ltd 皮膚外用剤
JPS62223115A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
KR950013750B1 (ko) * 1986-08-20 1995-11-15 테이고쿠 세이야쿠 가부시키가이샤 스테로이드제 함유 외용 첩부제(貼付劑)
US4740372A (en) * 1986-09-17 1988-04-26 Ljubomir Boncic Composition for treating psoriasis vulgaris and a method for its preparation
JPH0676328B2 (ja) * 1987-04-14 1994-09-28 株式会社大塚製薬工場 ステロイドクリ−ム製剤
US4865846A (en) * 1988-06-03 1989-09-12 Kaufman Herbert E Drug delivery system

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101103506B1 (ko) * 2007-07-19 2012-01-09 수자원기술 주식회사 관내부 라이닝을 위한 장치

Also Published As

Publication number Publication date
ES2090066T3 (es) 1996-10-16
KR950010157B1 (ko) 1995-09-11
EP0473810A1 (en) 1992-03-11
ES2074505T3 (es) 1995-09-16
KR910002426A (ko) 1991-02-25
JP2655190B2 (ja) 1997-09-17
DE69027213D1 (de) 1996-07-04
EP0473811A1 (en) 1992-03-11
DE69027213T2 (de) 1996-11-28
EP0473811B1 (en) 1995-05-03
US5094851A (en) 1992-03-10
JPH0338524A (ja) 1991-02-19
US5112816A (en) 1992-05-12
JP2646025B2 (ja) 1997-08-25
JP2660198B2 (ja) 1997-10-08
HK1007106A1 (en) 1999-04-01
DE69019151D1 (de) 1995-06-08
JPH0324015A (ja) 1991-02-01
DE69019151T2 (de) 1996-01-25
EP0473810B1 (en) 1996-05-29
SG47072A1 (en) 1998-03-20
JPH0338525A (ja) 1991-02-19
KR950015063B1 (ko) 1995-12-21

Similar Documents

Publication Publication Date Title
KR910000159A (ko) 코르티코 스테로이드 함유 연고제
KR920000315A (ko) 모다피닐의 용도
KR890011606A (ko) 항응고제
KR900018321A (ko) 액체 유기수소폴리실록산을 함유하는 가교결합 가능한 감압성 접착제
KR900000335A (ko) 히드록시알킬시스테인 유도체 및 이를 함유하는 거담제
KR830005863A (ko) 인체 융모성선자격 호르몬의 제조방법
KR890008235A (ko) 고무노화방지용 왁스
KR900007410A (ko) 칼슘/칼모덜린-의존성 프로테인 키나아제 ⅱ또는 프로테인 키나아제 c의 억제제로서 에틸렌디아민테트라 아세트산의 용도
KR870003689A (ko) 살충 조성물
KR850002395A (ko) 두발 발모제(發毛劑) 조성물
KR900015747A (ko) 간장관련 질병 치료제의 제조방법
KR900018115A (ko) 베타-락타마제 저해제의 제조방법
KR870008535A (ko) "밤"가루(율분)
KR880005337A (ko) 토 치 카
KR890012643A (ko) 루신(Leucine)에 의한 생체에너지원 대체 용도
KR880008221A (ko) 컴퓨터 뇌파 학습기
KR920021132A (ko) 좌 제
KR910004204A (ko) 갈랑긴(galangin)의 추출 방법 및 그 용도
KR890000075A (ko) 액정과 펄을 이용한 화장료 제조방법
KR890003308A (ko) 쑥을 사용한 흡연초 쑥권연
KR900018359A (ko) 머루주의 제조방법
KR910004552A (ko) 니트로아닐린술폰산, 및 페닐렌디아민술폰산의 제조방법
KR900014098A (ko) 프라스틱(pvc) 피복 금속의 분리 방법
KR920017696A (ko) 지오글리골산 또는 l시스테인염산염에 함유된 철분 제거방법
KR840009209A (ko) 재치반 겸용 설겆이 대야

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

FPAY Annual fee payment

Payment date: 20030909

Year of fee payment: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20040912

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20040912

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000